Stockscreener 앱 받기
513.12
1.51%
-7.88
United Therapeutics Corp 주식(UTHR)의 최신 뉴스
United Therapeutics (NASDAQ: UTHR) CEO sale part of 1,734,410-option 10b5-1 plan - Stock Titan
United Therapeutics (UTHR) legal chief sells 8,300 shares - Stock Titan
United Therapeutics (NASDAQ: UTHR) CEO trades under 1,734,410-option 10b5-1 plan - Stock Titan
United Therapeutics (NASDAQ:UTHR) Stands Out as a Quality Stock with Durable Profitability and Strong Returns - ChartMill
ETFs Investing in United Therapeutics Corporation Stocks - TradingView
United Therapeutics (UTHR) CEO sells shares under preset trading plan - Stock Titan
United Therapeutics Corp (UTHR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
United Therapeutics (UTHR) CEO exercises options, sells 9,500 shares - Stock Titan
MannKind Stock Plummets After Partner United Therapeutics Unveils New ‘Category Killer Product’ - Stocktwits
United Therapeutics (NASDAQ: UTHR) CEO sells 9,500 shares - Stock Titan
United Therapeutics (UTHR) Q2 2026 Earnings Call Transcript - AOL.com
United Therapeutics Completes Enrollment in Phase 3 PPF Trial of Tyvaso - marketscreener.com
United Therapeutics completes enrollment in lung fibrosis trial - Investing.com
United Therapeutics Corporation Announces Full Enrollment of the TETON-PPF Study of Inhaled Treprostinil for the Treatment of Progressive Pulmonary Fibrosis - marketscreener.com
United Therapeutics Corporation Completes Enrollment Of TETON-PPF Study Of Inhaled Treprostinil For Progressive Pulmonary Fibrosis - marketscreener.com
United Therapeutics Corporation (UTHR) Stock Analysis: Potential 30% Upside Captivates Investors - DirectorsTalk Interviews
Mid Cap Index Fund's United Therapeutics Corp(UTHR) Holding History - GuruFocus
United Therapeutics CEO Martine Rothblatt sells $4.79m in stock By Investing.com - Investing.com South Africa
United Therapeutics CEO Martine Rothblatt sells $4.79m in stock - Investing.com
United Therapeutics (UTHR) CEO Rothblatt exercises 9,500 options and sells 9,500 shares via 10b5-1 plan - Stock Titan
UTHR|United Therapeutics Corp|Price:499.730|Chg%:-1.540 - TradingKey
United Therapeutics CEO Rothblatt sells $4.89m in stock By Investing.com - Investing.com Nigeria
United Therapeutics CEO Rothblatt sells $4.89m in stock - Investing.com
Martine Rothblatt Sells 9,500 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat
United Therapeutics Corp (UTHR) CEO’s trust sells 9,500 shares under 10b5-1 plan - Stock Titan
United Therapeutics (UTHR) Stock Looks Undervalued Despite Fresh NDA Filings - simplywall.st
United Therapeutics (NASDAQ:UTHR): A Peter Lynch-Style GARP Play - ChartMill
United Therapeutics Corp (UTHR) CEO trades 9,500 shares after option exercise - Stock Titan
UNITED THERAPEUTICS CORP (UTHR.MX) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
United Therapeutics chairperson & CEO sells $5.05m in stock By Investing.com - Investing.com Australia
United Therapeutics (UTHR) CEO trades 9,500 shares under 10b5-1 plan - Stock Titan
United Therapeutics chairperson & CEO sells $5.05m in stock - Investing.com
Baylor College of Medicine strikes multimillion-dollar deal with United Therapeutics for transplant center - The Business Journals
United Therapeutics (UTHR) CEO trades 9,500 shares under 10b5-1 option plan - Stock Titan
Assenagon Asset Management S.A. Purchases 37,355 Shares of United Therapeutics Corporation $UTHR - MarketBeat
United Therapeutics (UTHR) CEO sells 9,500 shares after option exercise - Stock Titan
United Therapeutics (NASDAQ:UTHR) Sees Strong Trading VolumeShould You Buy? - MarketBeat
United Therapeutics EVP & general counsel Mahon sells $4.29m in shares - Investing.com South Africa
United Therapeutics Corporation $UTHR Shares Sold by Bank of America Corp DE - MarketBeat
United Therapeutics (NASDAQ:UTHR) CEO Sells 9,500 Shares of Stock - MarketBeat
United Therapeutics Balances Tyvaso Woes With Pipeline Wins - The Globe and Mail
United Therapeutics (UTHR) counsel exercises options, sells 8,300 shares - Stock Titan
United Therapeutics Corp (UTHR) CEO sells 9,500 shares under 10b5-1 plan - Stock Titan
Royal Bank Of Canada Has Lowered Expectations for United Therapeutics (NASDAQ:UTHR) Stock Price - marketbeat.com
United Therapeutics Q2 Earnings Beat Estimates, Revenues Miss Mark - Yahoo Finance
United Therapeutics Corp (UTHR) (Q2 2026) Earnings Call Highligh - GuruFocus
United Therapeutics Corporation Q2 2026 Earnings Call Summary - Yahoo Finance
BofA cuts United Therapeutics stock price target on Tyvaso sales - Investing.com
1.24%
0.24%
자본화:
|
볼륨(24시간):